Literature DB >> 8054525

Reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis.

S C Richardson1, R F Bishop, A L Smith.   

Abstract

Infection with reovirus serotype 3 (reo 3) has been postulated to be associated with extrahepatic biliary atresia (EHBA) in infants, and with neonatal hepatitis (NNH). We have investigated this association by assaying antireo 3 antibodies in sera from infants (aged < 4 months) with EHBA (n = 40), NNH (59), cholestatic liver disease due to other causes (61) and control infants with no liver disease (138). Antireo 3 immunoglobulins (Ig) of the G, A and M classes were measured by enzyme-linked immunosorbent assay. No differences in the prevalence of antireo 3 IgG or IgA were found between any of the four groups. A significantly higher prevalence of positive antireo 3 IgM was found in infants with EHBA (12/40), NNH (12/59) or cholestatic liver disease associated with parenteral nutrition (7/17), alpha-1 antitrypsin deficiency (4/15) or a variety of other causes (15/29) compared with control infants (13/138). These data support an association between reovirus 3 infection and cholestatic liver disease in infants. The nature of this association may differ for EHBA, NNH and cholestatic liver disease due to other causes, and remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054525     DOI: 10.1111/j.1440-1746.1994.tb01721.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  16 in total

Review 1.  Zebrafish: an important tool for liver disease research.

Authors:  Wolfram Goessling; Kirsten C Sadler
Journal:  Gastroenterology       Date:  2015-08-28       Impact factor: 22.682

Review 2.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 3.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

Review 4.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

5.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

Review 6.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

Review 7.  Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

Authors:  Ronald J Sokol; Ross W Shepherd; Riccardo Superina; Jorge A Bezerra; Patricia Robuck; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

8.  Reovirus serotypes elicit distinctive patterns of recall immunity in humans.

Authors:  Renée N Douville; Ruey-Chyi Su; Kevin M Coombs; F Estelle R Simons; Kent T Hayglass
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

Review 9.  The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease.

Authors:  Cara L Mack
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

10.  Attenuated reovirus displays oncolysis with reduced host toxicity.

Authors:  M Kim; K A Garant; N I zur Nieden; T Alain; S D Loken; S J Urbanski; P A Forsyth; D E Rancourt; P W K Lee; R N Johnston
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.